From: Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsia
Characteristics | Control | Preeclampsia | Statistical significance |
---|---|---|---|
Neonates | 30 | 30 | – |
Gestational age (weeks) | 38.3 ± 1.10 | 37.5 ± 2.18 | p = 0.1178 |
Gender: male/female (%) | 40 / 60 | 43.3 / 56.6 | – |
Delivery: Vaginal birth/Caesarean section (%) | 0 / 100 | 6 / 94 | – |
Birth weight (g) | 3152 ± 442.2 | 2638 ± 494.7 | p = 0.0006 |
Size (cm) | 49.52 ± 2.11 | 46.07 ± 4.41 | p = 0.0015 |
Apgar score 1 min | 7.87 ± 0.80 | 7.53 ± 0.90 | p = 0.0203 |
Apgar score 5 min | 8.96 ± 0.17 | 8.30 ± 0.73 | p = 0.0001 |
Silverman-Anderson test | 1.65 ± 0.57 | 1.47 ± 0.89 | p = 0.4378 |
Respiratory rate (breaths/minute) | 49.57 ± 7.94 | 52.68 ± 6.66 | p = 0.1620 |
Heart rate (beats/minute) | 143.6 ± 11.03 | 140.9 ± 12.09 | p = 0.4375 |
GOT (U/L) | 28.24 ± 8.29 | 31.37 ± 11.06 | p = 0.1859 |
GPT (U/L) | 9.05 ± 2.65 | 8.72 ± 3.18 | p = 0.6461 |
Creatinine (mg/dL) | 0.72 ± 0.31 | 0.72 ± 0.12 | p = 0.9578 |
T-Chol (mg/dL) | 62.14 ± 19.11 | 73.79 ± 26.78 | p = 0.0402 |
TAG (mg/dL) | 33.66 ± 10.80 | 38.61 ± 15.77 | p = 0.1325 |
HDL-C (mg/dL) | 31.38 ± 10.01 | 34.10 ± 14.78 | p = 0.3676 |
LDL-C (mg/dL) | 28.76 ± 13.30 | 37.53 ± 16.02 | p = 0.0188 |
Apo-A (mg/dL) | 88.69 ± 16.40 | 85.73 ± 30.35 | p = 0.6047 |
Apo-B (mg/dL) | 23.43 ± 6.79 | 30.69 ± 11.53 | p = 0.0019 |
CUPRAC protein (nmol TR-equivalent/mg protein) | 0.0355 ± 0.0185 | 0.0497 ± 0.0170 | p = 0.0069 |
CUPRAC non-protein (nmol TR-equivalent/mL plasma) | 1.04 ± 0.35 | 1.34 ± 0.36 | p = 0.0045 |